SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-081277
Filing Date
2017-03-14
Accepted
2017-03-14 08:22:03
Documents
6
Period of Report
2017-03-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d353034d8k.htm 8-K 14908
2 EX-99.1 d353034dex991.htm EX-99.1 12903
3 EX-99.2 d353034dex992.htm EX-99.2 24529
4 GRAPHIC g353034ex991pg01a.jpg GRAPHIC 14469
5 GRAPHIC g353034ex991pg01b.jpg GRAPHIC 41218
6 GRAPHIC g353034ex992pg03.jpg GRAPHIC 41556
  Complete submission text file 0001193125-17-081277.txt   187945
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 17686958
SIC: 2834 Pharmaceutical Preparations